Sedation, Analgesia, and Muscle Relaxation During VV-ECMO Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2): A Single-Center, Retrospective, Observational Study

Objective: The pharmacokinetics and pharmacodynamics of ECMO-supported sedative, analgesic, and muscle relaxants have changed, but there are insufficient data to determine the optimal dosing strategies for these agents. Sedation, analgesia and muscle relaxation therapy for patients with severe acute...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Fang Wu, Mingna Li, Zhongwei Zhang, Jiawei Shang, Yong Guo, Yingchuan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Subjects:	VV-ECMO SARS-CoV-2 sedation analgesia muscle relaxant
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.762740/full